Lilly Says Retatrutide Reduced A1C and Produced Weight Loss in Phase 3 Trial
Photo: TokenPost
Eli Lilly said Wednesday, Oct. 28, that retatrutide produced weight loss and reduced A1C in a Phase 3 trial. John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.
Source: TokenPost
